Holding(s) in Company

For filings with the FSA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:ii Worldwide Healthcare Trust PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): Transfer into Nominees X 3. Full name of person(s) subject to the Investec Wealth & Investment notification obligation:iii Limited 4. Full name of shareholder(s) N/A (if different from 3.):iv 5. Date of the transaction and date on 28th August 2012 which the threshold is crossed or reached: v 6. Date on which issuer notified: 29th August 2012 7. Threshold(s) that is/are crossed or From 6% to 8% reached: vi, vii 8. Notified details: A: Voting rights attached to shares viii, ix Class/type of Situation previous Resulting situation after the triggering shares to the triggering transaction transaction if possible Number Number Number Number of voting % of voting rights using of of of rights x the ISIN CODE Shares Voting shares Rights Direct Direct Indirect xii Direct Indirect xi Ordinary Shares 3,183,933 3,183,933 3,783,926 8.31% GB0003385308 B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ Number of % of financial date xiii Conversion Period xiv voting voting instrument rights that rights may be acquired if the instrument is exercised/ converted. Subscription 31 July 131,129 0.29% Shares 2014 31 October, 31 January, 30 April & 31 GB00B3VMCB07 July up to 31 July 2014 C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction Type of Exercise Expiration Exercise/ Number of voting rights % of voting financial price date xvii Conversion instrument refers to rights xix, xx instrument period xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 3,915,055 8.60% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi Client holdings registered in the name of Nominee companies 100% owned by Investec Wealth & Investment Limited. NB: The increase in the Nominee holding triggering this disclosure is the result of the integration of the Williams De Broe business with Investec Wealth & Investment on 28th August 2012. Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A Phil Beardwell Chartered FCSI 14. Contact name: Senior Compliance Manager 15. Contact telephone number: 020 7597 1356 Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in sharesxxii A: Identity of the persons or legal entity subject to the notification obligation Full name Investec Wealth & Investment Limited (including legal form of legal entities) Contact address 2 Gresham Street (registered office for legal entities) London EC2V 7QP Phone number & email 0113 236 4171 mike.rigby@investecwin.co.uk Other useful information Mike Rigby (at least legal representative for legal persons) (Head of Compliance) B: Identity of the notifier, if applicable Full name Philip Martin Beardwell Contact address 2 Gresham Street London EC2V 7QN Phone number & email 020 7597 1356 phil.beardwell@investecwin.co.uk Other useful information Senior Compliance Manager (e.g. functional relationship with the person or legal entity subject to the notification obligation) C: Additional information For notes on how to complete form TR-1 please see the FSA website.
Investor Meets Company
UK 100